EUVIMEDEUVIMED entdecken
Crossref

Abstract 7342: Missed and Delayed Arrhythmia Recognition in FDA MAUDE Reports for Cardiac Rhythm-Monitoring Devices

Joyce Gu, Daniel Yow, Wenchy Tan, Hyunwoo Kim, Samuel Tan

Circulation · 02.11.2026 · 154 (Suppl_1)

DOI: 10.1161/circ.154.suppl_1.7342 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation, erschienen am 02.11.2026. Verfasst von Joyce Gu und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cardiac rhythm-monitoring systems depend on sensing algorithms, remote transmission, alert rules, and final report workflows. A clinically important safety event occurs when a true arrhythmia is not detected, transmitted, or communicated in time for expected action. Research Question: Among FDA MAUDE reports for cardiac rhythm-monitoring devices, what true arrhythmias were missed or delayed, and where did recognition fail?

Methods

We analyzed 2024-2025 MAUDE device and narrative files. Rhythm monitoring reports were identified from device-table product descriptors for external patch monitors, insertable/implantable cardiac monitors, and consumer ECG devices, then deduplicated by MDR_REPORT_KEY. Reports met the primary endpoint only when the narrative supported both a true rhythm event and its missed or delayed clinical response. Generic device performance problems, false-positive rhythms, skin/site events, and routine device management without a stated missed rhythm event were excluded. First-pass structured extraction used a large language model; all positive and unclear reports were manually adjudicated.

Results

The cohort included 9,355 reports: 4,488 from 2024 and 4,867 from 2025. After adjudication, 605 reports (6.5%) described missed or delayed true arrhythmia recognition, 25 (0.3%) remained unclear, and 8,725 (93.3%) did not meet the endpoint. When rhythm type was specified, missed/delayed events involved clinically important diagnoses including pause/asystole (59, 9.8%), atrial fibrillation/flutter (24, 4.0%), ventricular tachyarrhythmia (18, 3.0%), tachycardia (14, 2.3%), and AV block/bradycardia (9, 1.5%). The dominant failure points were algorithm/detection criteria (310, 51.2%) and transmission/connectivity (247, 40.8%). Reports that were negative for the endpoint were common and were dominated by battery/power/reset issues, sensing or false-positive rhythm reports, telemetry/connectivity problems without a missed arrhythmia, and skin or implant-site complications.

Conclusions

MAUDE narratives identified a focused postmarket signal of missed or delayed recognition of true arrhythmias in rhythm-monitoring workflows. The main clinical pattern was not a single rhythm diagnosis, but rather the failure of monitoring systems to detect, transmit, or communicate actionable rhythm events. These findings should be interpreted as postmarket reporting signals, not incidence estimates or comparative device risk rates.

Zitieren

APA

Gu, J., Yow, D., Tan, W., Kim, H., & Tan, S. (2026). Abstract 7342: Missed and Delayed Arrhythmia Recognition in FDA MAUDE Reports for Cardiac Rhythm-Monitoring Devices. Circulation, 154(Suppl_1). https://doi.org/10.1161/circ.154.suppl_1.7342

Vancouver

Gu J, Yow D, Tan W, Kim H, Tan S. Abstract 7342: Missed and Delayed Arrhythmia Recognition in FDA MAUDE Reports for Cardiac Rhythm-Monitoring Devices. Circulation. 2026;154(Suppl_1). doi:10.1161/circ.154.suppl_1.7342

BibTeX
@article{Gu2026,
  author = {Gu, Joyce and Yow, Daniel and Tan, Wenchy and Kim, Hyunwoo and Tan, Samuel},
  title = {Abstract 7342: Missed and Delayed Arrhythmia Recognition in FDA MAUDE Reports for Cardiac Rhythm-Monitoring Devices},
  journal = {Circulation},
  year = {2026},
  volume = {154},
  number = {Suppl_1},
  doi = {10.1161/circ.154.suppl_1.7342}
}
Kostenlos starten →